The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management

por Keup, Corinna, Kimmig, Rainer, Kasimir-Bauer, Sabine
Publicado 2023

Combinatorial Power of cfDNA, CTCs and EVs in Oncology

por Keup, Corinna, Kimmig, Rainer, Kasimir-Bauer, Sabine
Publicado 2022

Association of Soluble B7-H4 and Circulating Tumor Cells in Blood of Advanced Epithelial Ovarian Cancer Patients

por Mach, Pawel, Kimmig, Rainer, Kasimir-Bauer, Sabine, Buderath, Paul
Publicado 2021

Patient Preferences for Oral Anticoagulation Therapy in Atrial Fibrillation: A Systematic Literature Review

por Wilke, Thomas, Bauer, Sabine, Mueller, Sabrina, Kohlmann, Thomas, Bauersachs, Rupert
Publicado 2016

Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells

por Kasimir-Bauer, Sabine, Hoffmann, Oliver, Wallwiener, Diethelm, Kimmig, Rainer, Fehm, Tanja
Publicado 2012

Comparison of three molecular assays for the detection and molecular characterization of circulating tumor cells in breast cancer

por Strati, Areti, Kasimir-Bauer, Sabine, Markou, Athina, Parisi, Cleo, Lianidou, Evi S
Publicado 2013

RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulati...

por Giannopoulou, Lydia, Chebouti, Issam, Pavlakis, Kitty, Kasimir-Bauer, Sabine, Lianidou, Evi S.
Publicado 2017

In Early Breast Cancer, the Ratios of Neutrophils, Platelets and Monocytes to Lymphocytes Significantly Correlate with the Presence of Subsets of Circulating Tumor Cells but Not wi...

por Kasimir-Bauer, Sabine, Karaaslan, Ebru, Hars, Olaf, Hoffmann, Oliver, Kimmig, Rainer
Publicado 2022

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

por Aktas, Bahriye, Tewes, Mitra, Fehm, Tanja, Hauch, Siegfried, Kimmig, Rainer, Kasimir-Bauer, Sabine
Publicado 2009

Longitudinal Multi-Parametric Liquid Biopsy Approach Identifies Unique Features of Circulating Tumor Cell, Extracellular Vesicle, and Cell-Free DNA Characterization for Disease Mon...

por Keup, Corinna, Suryaprakash, Vinay, Storbeck, Markus, Hoffmann, Oliver, Kimmig, Rainer, Kasimir-Bauer, Sabine
Publicado 2021

LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival

por Kuhlmann, Jan Dominik, Schwarzenbach, Heidi, Wimberger, Pauline, Poetsch, Micaela, Kimmig, Rainer, Kasimir-Bauer, Sabine
Publicado 2012

Molecular characterization of circulating tumour cells identifies predictive markers for outcome in primary, triple‐negative breast cancer patients

por Bittner, Ann‐Kathrin, Keup, Corinna, Hoffmann, Oliver, Hauch, Siegfried, Kimmig, Rainer, Kasimir‐Bauer, Sabine
Publicado 2020

Circulating Tumor Cells Expressing the Prostate Specific Membrane Antigen (PSMA) Indicate Worse Outcome in Primary, Non-Metastatic Triple-Negative Breast Cancer

por Kasimir-Bauer, Sabine, Keup, Corinna, Hoffmann, Oliver, Hauch, Siegfried, Kimmig, Rainer, Bittner, Ann-Kathrin
Publicado 2020

Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer

por Schwarzenbach, Heidi, Pantel, Klaus, Kemper, Birthe, Beeger, Cord, Otterbach, Friedrich, Kimmig, Rainer, Kasimir-Bauer, Sabine
Publicado 2009

Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression

por Roth, Carina, Pantel, Klaus, Müller, Volkmar, Rack, Brigitte, Kasimir-Bauer, Sabine, Janni, Wolfgang, Schwarzenbach, Heidi
Publicado 2011

ATMIN is required for the ATM-mediated signaling and recruitment of 53BP1 to DNA damage sites upon replication stress

por Schmidt, Luisa, Wiedner, Marc, Velimezi, Georgia, Prochazkova, Jana, Owusu, Michel, Bauer, Sabine, Loizou, Joanna I.
Publicado 2014

Analysis of disseminated tumor cells before and after platinum based chemotherapy in primary ovarian cancer. Do stem cell like cells predict prognosis?

por Chebouti, Issam, Blassl, Christina, Wimberger, Pauline, Neubauer, Hans, Fehm, Tanja, Kimmig, Rainer, Kasimir-Bauer, Sabine
Publicado 2016

Evaluation of a novel ELISA for the tumor-associated antigen CA 72–4 in patients with ovarian cancer

por Buderath, Paul, Kasimir-Bauer, Sabine, Aktas, Bahriye, Rasch, Jens, Kimmig, Rainer, Zeller, Thomas, Heubner, Martin
Publicado 2016

Treatment of relapsed refractory multiple myeloma: which new PI-based combination treatments do patients prefer?

por Wilke, Thomas, Mueller, Sabrina, Bauer, Sabine, Pitura, Silvia, Probst, Leona, Ratsch, Boris A, Salwender, Hans
Publicado 2018

Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy

por Kasimir-Bauer, Sabine, Bittner, Ann-Kathrin, König, Lisa, Reiter, Katharina, Keller, Thomas, Kimmig, Rainer, Hoffmann, Oliver
Publicado 2016